close

Perrigo Company, through its subsidiaries, develops, manufactures, and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, active pharmaceutical ingredients (API), and consumer products worldwide. The company operates through three segments: Consumer Healthcare, Rx Pharmaceuticals, and API. The Consumer Healthcare segment offers OTC pharmaceutical and nutritional products, which include analgesic, cough/cold/allergy/sinus, gastrointestinal, smoking cessation, first aid, and vitamin and nutritional supplement products. The Rx Pharmaceuticals segment develops, manufactures, and markets topical generic prescription drug products, including creams, ointments, lotions, gels, shampoos, suppositories, liquid suspensions, and solutions, as well as nasal sprays, oral liquids, and transdermal products. The API segment engages in the development, manufacture, and marketing of APIs used by the generic drug industry and branded pharmaceutical companies. Perrigo Company also provides consumer products, such as cosmetics, toiletries, bar soaps, and detergents; manufactures and markets branded prescription drugs; and imports pharmaceutical, diagnostics, and other medical products. Its customers primarily include retail drug, supermarket, wholesalers, and mass merchandise chains. The company was founded in 1887 and is based in Allegan, Michigan.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	103.68
Volume	727532
Volume Avg	(mio) 1.33
52 Week High	108.50
52 Week Low	72.51
PE	28.38
PE (group average)	39
EPS Year	3.67
EPS change Q/Q	-2.04%
EPS change Q/Q Yr ago	41.18%
EPS change Q/Q next Q est	-25%
EPS change Y/Y	-30.7%
REV change Q/Q	-3.61%
REV change Q/Q Yr ago	28.65%
EPS next Q est	1.28
EPS next Y est	5.42
Divident Annual	0.30
Dividend Yield	0.29%